| Revenue | 31/12/2018 | 31/12/2017 | 31/12/2016 | 31/12/2015 |
| Total revenue | 2,472,300 | 2,412,300 | 2,168,100 | 1,759,000 |
| Cost of revenue | 514,200 | 474,900 | 376,100 | 310,200 |
| Gross profit | 1,958,100 | 1,937,400 | 1,792,000 | 1,448,800 |
| Operating expenses |
| Research development | - | - | - | - |
| Selling general and administrative | 1,364,000 | 1,329,600 | 1,197,600 | 965,700 |
| Non-recurring | - | - | - | - |
| Others | 102,800 | 93,600 | 92,900 | 64,000 |
| Total operating expenses | 2,189,200 | 2,096,800 | 1,910,800 | 1,542,200 |
| Operating income or loss | 283,100 | 315,500 | 257,300 | 216,800 |
| Income from continuing operations |
| Total other income/expenses net | -397,200 | 398,100 | -48,800 | -57,800 |
| Earnings before interest and taxes | 283,100 | 315,500 | 257,300 | 216,800 |
| Interest expense | -54,900 | -47,300 | -48,500 | -48,500 |
| Income before tax | -114,100 | 713,600 | 208,500 | 159,000 |
| Income tax expense | -15,800 | 30,600 | 40,700 | 34,700 |
| Minority interest | 400 | 300 | 100 | -200 |
| Net income from continuing ops | -98,300 | 683,000 | 167,800 | 124,300 |
| Non-recurring events |
| Discontinued operations | - | - | - | - |
| Extraordinary items | - | - | - | - |
| Effect of accounting changes | - | - | - | - |
| Other items | - | - | - | - |
| Net income |
| Net income | -98,300 | 683,000 | 167,800 | 124,300 |
| Preferred stock and other adjustments | - | - | - | - |
| Net income applicable to common shares | -98,300 | 683,000 | 167,800 | 124,300 |